Latest International Growth News

Page 1 of 20
AUB Group has raised the lower end of its FY27 underlying profit guidance to A$250 million after delivering 12.2% growth in FY26 earnings. The insurance broker is now balancing international expansion and acquisitions against weaker New Zealand performance, higher funding costs and integration demands.
Victor Sage
Victor Sage
12 Nov 2026
Biome Australia has secured an exclusive mainland China cross-border e-commerce agreement with H&S Global, targeting A$2.0 million in Year 1 purchases from an early 2027 launch. The target is larger than Biome’s entire FY26 international sales, but the company will fund 25% of Year 1 invoiced value in marketing and operational support.
Ada Torres
Ada Torres
9 Nov 2026
Monster Beverage delivered a strong third quarter, with sales rising 16.7% to US$2.56 billion and international revenue climbing 28.1%. The trade-off was narrower margins as aluminium, freight, fuel, marketing and transformation costs increased.
Victor Sage
Victor Sage
6 Nov 2026
Live Nation delivered a record third quarter as revenue climbed 19% to US$10.1 billion and attendance surged worldwide. International markets supplied most of the growth in fans and ticketing, while the company raised its 2026 attendance expectations and accelerated venue investment.
Elise Vega
Elise Vega
6 Nov 2026
McDonald’s delivered higher profit and systemwide sales in the third quarter, helped by international markets, franchise margins and other operating income. The slight decline in US comparable sales remains the clearest test of whether its value push can restore guest traffic.
Logan Eniac
Logan Eniac
4 Nov 2026
Insulet delivered a stronger-than-expected third quarter, with revenue up 19.2% and adjusted earnings per share rising nearly 60%. The diabetes-device maker also raised its operating-margin outlook and authorised a US$1 billion share repurchase programme.
Ada Torres
Ada Torres
4 Nov 2026
IDEXX Laboratories has raised its 2026 revenue and earnings outlook after reporting 10% third-quarter revenue growth and an 18% rise in diluted EPS. The upgrade came alongside rapid adoption of its inVue Dx analyzers, although acquisition costs prompted a lower full-year operating margin forecast.
Ada Torres
Ada Torres
2 Nov 2026
Kelsian Group has entered FY27 after a record financial year, the $149.9 million sale of its Tourism Portfolio and a sharp reduction in leverage. But the transport operator is also awaiting an independent review into a fatal June bus incident as it pursues fresh international growth.
Victor Sage
Victor Sage
27 Oct 2026
Amotiv has cut its FY27 revenue and underlying EBITA outlook by up to 5% after first-quarter revenue fell 5% on weaker vehicle demand and Thailand flooding. The ASX-listed automotive parts group will nevertheless launch another buyback of up to 5% of its shares, betting its depressed valuation will recover.
Victor Sage
Victor Sage
27 Oct 2026
Pureprofile has started FY27 with record quarterly revenue of $18.3 million and EBITDA of $2.4 million, while Platform revenue more than doubled. The ASX-listed data and insights company maintained its revenue guidance and lifted its EBITDA margin outlook to 11% to 12%.
Victor Sage
Victor Sage
26 Oct 2026
Monash IVF Group’s underlying NPAT fell 41% to A$16.1 million in FY26, missing its recently reduced guidance as softer Australian IVF activity outweighed international growth. A second-half market-share recovery, lower planned capital spending and a new productivity program now carry the FY27 investment case.
Ada Torres
Ada Torres
23 Oct 2026
Skellerup says FY27 has begun strongly, with first-quarter net profit after tax up 15% on the prior comparative period. The NZX-listed industrial products maker is forecasting full-year NPAT of $67 million to $72 million, while warning that geopolitical unrest and higher costs could weigh on demand.
Victor Sage
Victor Sage
21 Oct 2026

Browse the archive

Full archive